지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-analysis
대한외과학회 학술대회 초록집
2022 .11
The Role of Neoadjuvant Treatment in Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2019 .10
Great Debates: Which is the Best? Resectable pancreatic cancer: Neoadjuvant treatment first
대한임상종양학회 학술대회지
2019 .02
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2022 .01
Superior Mesenteric Vein and Portal Vein Patency after Pancreaticoduodenectomy: A Single Center Retrospective Study
대한외과학회 학술대회 초록집
2018 .11
Upfront liver resection in patients with resectable hepatocellular carcinoma with portal vein tumor thrombus
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Acute Appendicitis with Superior Mesenteric Vein and Portal Vein Thrombophlebitis
대한외과학회 학술대회 초록집
2018 .11
Development of Deep Learning Prognostic Model for Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2021 .11
Comparison between neoadjuvant chemotherapy and upfront surgery for patients with resectable and synchronous colorectal cancer hepatic metastases
대한임상종양학회 학술대회지
2019 .02
Laparoscopic pancreaticoduodenectomy with segmental resection of superior mesenteric vein-splenic vein-portal vein confluence in pancreatic head cancer : can it be a standard procedure?
Annals of Hepato-Biliary-Pancreatic Surgery
2018 .11
Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2023 .03
Neoadjuvant chemotherapy followed by total pancreatectomy with splenectomy and combined vascular resections after preoperative percutaneous transhepatic portal vein stent placement in locally advanced pancreatic cancer with portal vein total obliteration
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .11
Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
The comparison of short-term postoperative outcomes between upfront surgery and surgery following neoadjuvant treatment in pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Clinical significance of defining borderline resectable pancreatic cancer
한국간담췌외과학회 학술대회지
2017 .03
Validation of anatomical and biological definition of borderline resectable cancer according to the 2017 international consensus for survival in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma undergoing upfront surgery
대한임상종양학회 학술대회지
2022 .02
Does a High Circulating Tumor Cell Count in Portal Vein Predict the Involvement of Portal System in Pancreatic Cancer Patients?
대한외과학회 학술대회 초록집
2018 .11
Role of neoadjuvant treatment for resectable pancreatic ductal adenocarcinoma
한국간담췌외과학회 학술대회지
2017 .03
Upfront surgery
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
대한췌담도학회지
2020 .01
0